Federal Register #FDA2026N8692

FDA announces public advisory committee meeting on pathogen-agnostic sequencing for emergency preparedness.

This opportunity is a public advisory committee meeting hosted by the FDA to discuss pathogen-agnostic sequencing for emergency preparedness and response. - Event Details: - Hosted by the Food and Drug Administration (FDA), Department of Health and Human Services - Focuses on pathogen-agnostic sequencing technologies for outbreak response - Seeks advice and recommendations from the Microbiology Devices Panel of the Medical Devices Advisory Committee - Participation: - Open to the public, including stakeholders and industry representatives - Public docket established for written comments - Opportunities for oral and written presentations - Virtual meeting platform to enable broad participation - Procurement/Products: - No products, services, or OEMs are being requested or procured - No specific vendors or manufacturers mentioned - Unique Requirements: - Emphasis on scientific, clinical, and public health aspects - Focus on emergency preparedness for both known and unknown pathogens

Description

The Food and Drug Administration (FDA) announces a public advisory committee meeting of the Microbiology Devices Panel of the Medical Devices Advisory Committee. The committee will provide advice and recommendations on the use of pathogen-agnostic sequencing in emergency preparedness and response efforts, including local and national outbreaks, known or unknown pathogens. The meeting is scheduled for November 19, 2026, and will be held virtually with public participation options. A public docket for comments is established to gather input on the scientific, clinical, and public health aspects of pathogen-agnostic sequencing.

View original listing